Abstract: An embodiment of the present invention relates to a storage container for liquids or for viscous or atomizable products, which can be connected to a metering device, the storage container having a cylindrical configuration and a base with a pressure equalization device and also an oppositely situated open side, the open side including a connection region, and in that an inner bag which is collapsible by suction force is disposed in the storage container.

Abstract: The present invention relates to a metering device for metered output of liquid preparations in the medicinal, pharmaceutical or cosmetic field or in the foodstuffs sphere, the use of preservatives being able to be dispensed with. Furthermore, the invention relates to a method for filling and also the use of a metering device according to the invention.

Abstract: The present invention relates to a metering device for metered dispensing of liquid preparations, in particular for metering medicinal, pharmaceutical and cosmetic liquid preparations, the use of preservatives being able to be dispensed with.

Abstract: An embodiment of the present invention relates to a storage container for liquids or for viscous or atomisable products, which can be connected to a metering device, the storage container having a cylindrical configuration and a base with a pressure equalisation device and also an oppositely situated open side, the open side including a connection region, and in that an inner bag which is collapsible by suction force is disposed in the storage container.

Abstract: A molecularly imprinted polymer and production process therefor and a process for selective treatment of poorly degradable and/or toxic compounds in liquids using the molecularly imprinted polymers. Such polymers and processes are required for selective removal and/or degradation of biological, poorly degradable pollutants or toxic compounds, for example from wastewaters. Consequently, a molecularly imprinted polymer suitable for the selective treatment of at least one poorly degradable and/or toxic compound is provided having a polymeric network which is made up of monomers and has cavities of predetermined size, wherein the cavities are arranged at predetermined spacings and have specific binding sites and/or patterns for the poorly degradable and/or toxic compounds.

Abstract: The present invention relates to a polymer matrix for specifically tethering surface epitopes or receptors of cells, said polymer matrix having been pretreated by molecular imprinting. The invention also relates to a method of producing such a polymer matrix. The polymer matrices according to the present invention are used in therapeutic and diagnostic applications as well as for isolating cells.

Abstract: The present invention relates to a cell modification method for modifying human or mammal immune cells, especially effector cells outside the human or mammal body, wherein in a first step at least one encapsulated substance, preferably an active pharmaceutical ingredient, is introduced in and/or arranged on isolated human or mammal immune cells and wherein in a second step prior to or after the introduction of said at least one substance the cytotoxic effector function of the isolated immune cells is enhanced. The present invention also relates to a correspondingly modified human or mammal immune cell and to a cell modification device.

Abstract: The present invention relates to a device and to a method for the isolation of biological particles. This device has a throughflow channel 5 and also a first and second magnetic field and also two inlet channels 1, 2 and two outlet channels 3, 4. The first magnetic field is disposed downstream of the inflow region of the inlet channels laterally of the throughflow channel 5, the second magnetic field 7 downstream of the first magnetic field 6 and on the oppositely situated side of the throughflow channel 5. The two magnetic fields can be produced also by a single magnet in a suitable arrangement.

Abstract: The present invention relates to a micromedical cell processor which modifies the cellular components of blood, especially cells of the body's natural immune defense, such that the cells, after their introduction into the body, exert a therapeutic function against cancerous diseases or against other diseases. The cell processor is implantable in the human or animal body and has a device for isolating cells, a device for fixing the cells, a device for introducing substances into the cells, and a device for determining the concentration of substances in the cells. The cell processor can also be used outside the body for loading the cells.